Preclinical studies on the molecular basis of Bortezomib resistance and modalities to overcome resistance in hematological malignancies.

J. Cloos, D. Niewerth, G. Jansen

Research output: Chapter in Book/Report/Conference proceedingChapterAcademic

Original languageUndefined/Unknown
Title of host publicationResistance to proteasome inhibitors in cancer
Pages181-204
Publication statusPublished - 2014

Publication series

Name
Number7

Cite this